Correlation Between Immix Biopharma and X4 Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Immix Biopharma and X4 Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immix Biopharma and X4 Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Immix Biopharma and X4 Pharmaceuticals, you can compare the effects of market volatilities on Immix Biopharma and X4 Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immix Biopharma with a short position of X4 Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immix Biopharma and X4 Pharmaceuticals.
Diversification Opportunities for Immix Biopharma and X4 Pharmaceuticals
0.41 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Immix and XFOR is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Immix Biopharma and X4 Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on X4 Pharmaceuticals and Immix Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immix Biopharma are associated (or correlated) with X4 Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of X4 Pharmaceuticals has no effect on the direction of Immix Biopharma i.e., Immix Biopharma and X4 Pharmaceuticals go up and down completely randomly.
Pair Corralation between Immix Biopharma and X4 Pharmaceuticals
Given the investment horizon of 90 days Immix Biopharma is expected to under-perform the X4 Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Immix Biopharma is 2.91 times less risky than X4 Pharmaceuticals. The stock trades about -0.11 of its potential returns per unit of risk. The X4 Pharmaceuticals is currently generating about -0.03 of returns per unit of risk over similar time horizon. If you would invest 58.00 in X4 Pharmaceuticals on October 25, 2024 and sell it today you would lose (9.00) from holding X4 Pharmaceuticals or give up 15.52% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Immix Biopharma vs. X4 Pharmaceuticals
Performance |
| Timeline |
| Immix Biopharma |
| X4 Pharmaceuticals |
Immix Biopharma and X4 Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Immix Biopharma and X4 Pharmaceuticals
The main advantage of trading using opposite Immix Biopharma and X4 Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immix Biopharma position performs unexpectedly, X4 Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in X4 Pharmaceuticals will offset losses from the drop in X4 Pharmaceuticals' long position.| Immix Biopharma vs. ZyVersa Therapeutics | Immix Biopharma vs. Hepion Pharmaceuticals | Immix Biopharma vs. Cns Pharmaceuticals | Immix Biopharma vs. Sonnet Biotherapeutics Holdings |
| X4 Pharmaceuticals vs. Terns Pharmaceuticals | X4 Pharmaceuticals vs. Day One Biopharmaceuticals | X4 Pharmaceuticals vs. Hookipa Pharma | X4 Pharmaceuticals vs. Amylyx Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |